Wells Fargo downgraded NOV Inc. to Underweight from Equal Weight with a price target of $16, down from $20.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
- NOV Inc. price target lowered to $23 from $25 at Morgan Stanley
- NOV Inc. Secures New Credit Facility and Terminates Old Agreement
- Ex-Dividend Date Nearing for These 9 Stocks – Week of September 9, 2024
- Seaport Research oilfield services analyst has analyst/industry conference call
- NOV Inc. price target raised to $20 from $17 at Barclays